Procopio, G., Cognetti, F., Miceli, R., Milella, M., Mosca, A., Chiuri, V. E., Bearz, A., Morelli, F., Ortega, C., Atzori, F., Passalacqua, R., Ratta, R., de Braud, F. G. M., Cappelletti, V., & Verzoni, E. (n.d.). 880PSubgroups analysis and circulating biomarkers evaluation of RESORT trial: A randomized phase II study in metastatic renal cell carcinoma (mRCC) patients (pts) to evaluate the efficacy of sorafenib after metastasectomy. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095505754.0x00003a